Joshua D. Kassner, MD, is a senior fellow in Hematology and Medical Oncology with training in internal medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, where he serves in the Division of Hematology and Medical Oncology within the Weill Department of Medicine. His clinical work centers on hematologic oncology, antibody-based and cellular immunotherapies, and the management of complex relapsed or treatment-resistant blood cancers. Dr. Kassner’s research interests include optimization of novel immunotherapies, mechanisms of treatment response and resistance, and genomic risk stratification in myeloid and plasma cell malignancies. He has contributed to multi-institutional clinical research presented at major hematology and oncology meetings, including ASH and IMS, and is an active member of collaborative translational and outcomes research teams with interests in health equity, diverse patient populations, and innovative therapeutic strategies. He earned his MD from Georgetown University School of Medicine, then completed his Internal Medicine residency at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, where he is currently completing fellowship training in Hematology and Medical Oncology.
Fellow
Medical School
2017 – 2021
Residency
2021 – 2024
Fellowship
2024 – 2027